News

T-Balance Therapeutics is a young start-up company that is developing a monoclonal antibody with the aim of exploiting the potential of this molecule in inflammatory diseases. The company recently opened a location in the Potsdam Science Park. The small, international team of scientists and physicians with solid expertise in all major areas of drug development…

Good transport connections are of the utmost importance for the more than 13,000 employees and students in the Potsdam Science Park, the largest science location in Brandenburg. In the summer of 2020, the University of Potsdam and the site management of the Potsdam Science Park conducted an extensive survey to determine which transport connections are…

University of Potsdam | Success story: Just last year, we spoke with Signavio founder Dr. Gero Decker in an interview about the founding phase of the company, and now the startup, which is funded by the University of Potsdam, is being taken over by the software company SAP for one billion euros. Graduates of the…

MPIKG | As part of the Henriette Herz Scouting Programme, Prof. Dr. Markus Antonietti can now directly select three excellent young international chemists for a fellowship from the Alexander von Humboldt Foundation.

Fraunhofer IAP | On January 1, 2021, the new Emmy Noether Group “Next Generation Antimicrobial Polymers” began its work at the University of Potsdam in close cooperation with the Fraunhofer Institute for Applied Polymer Research IAP. The aim is to develop antimicrobial polymers that can replace antibiotics.

MPICI | Professor Peter H. Seeberger will be the first German researcher to hold the Newton-Abraham Visiting Professorship at the University of Oxford, for one year starting in October 2021. Seeberger thus joins the ranks of renowned and highly distinguished researchers from the fields of chemistry, biology and medicine – including four Nobel Prize winners.